{"output": [["Pharmaceutical Industry", "SECTOR", "Has", "Wave of Megamergers", "EVENT"], ["Pharmaceutical Industry", "SECTOR", "Has", "Conditions Right for Sequel", "EVENT"], ["Pfizer", "COMP", "Announce", "Acquisition of Wyeth", "ORG"], ["Merck & Co.", "COMP", "Announce", "Acquisition of Schering-Plough", "ORG"], ["Pharmaceutical Industry", "SECTOR", "Raise", "Concerns about Growth", "CONCEPT"], ["Pharmaceutical Industry", "SECTOR", "Raise", "Tougher Regulations", "CONCEPT"], ["Pharmaceutical Companies", "SECTOR", "Boost", "List Prices", "CONCEPT"], ["Pharmaceutical Companies", "SECTOR", "Pay", "Rebates to PBMs", "ORG"], ["Biopharma Companies", "SECTOR", "Reduced Ability to Increase", "Net Realized Price", "CONCEPT"], ["Pharmaceutical Industry", "SECTOR", "Relate_To", "Consolidation in Health Care", "SECTOR"], ["Pfizer", "COMP", "Participates_In", "Acquisition of Medivation", "ORG"], ["Gilead Sciences", "COMP", "Participates_In", "Acquisition of Kite Pharma", "ORG"], ["Pfizer", "COMP", "Control", "Medivation", "ORG"], ["Gilead Sciences", "COMP", "Control", "Kite Pharma", "ORG"], ["Pfizer", "COMP", "Impact", "Relative Scarcity of Targets", "CONCEPT"], ["Pharmaceutical Industry", "SECTOR", "Operate_In", "U.S.", "GPE"], ["Pharmaceutical Companies", "SECTOR", "Invests_In", "Branded Drug Companies", "SECTOR"], ["Pharmaceutical Companies", "SECTOR", "Participates_In", "Opportunities for Partnering", "CONCEPT"], ["Pharmaceutical Industry", "SECTOR", "Face", "Regulatory Approval", "CONCEPT"], ["Pharmaceutical Industry", "SECTOR", "Face", "Integration Concerns", "CONCEPT"]], "published": "2018-01-05T12:30:00.000+02:00"}